More on IMMX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $12.70 |
|
|||
| Open | $12.86 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $13.29 | ||||
| Day Low | $12.02 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 1,190,508 | ||||
- Form SCHEDULE 13G Immix Biopharma, Inc. Filed by: EVENTIDE ASSET MANAGEMENT, LLC
- Immix Biopharma (IMMX) Reiterated at Market Outperform by Citizens on Upcoming Milestones
- Form SCHEDULE 13G/A Immix Biopharma, Inc. Filed by: Janus Henderson Group Ltd.
- Immix Biopharma, Inc. (IMMX) PT Lowered to $19 at Morgan Stanley
- Immix Biopharma, Inc. (IMMX) PT Raised to $25 at H.C. Wainwright
- Form 10-Q Immix Biopharma, Inc. For: Jun 30
- Immix Biopharma to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
- IMMX INVESTIGATION: Securities Fraud Investigation by Block & Leviton Could Allow Immix Biopharma Investors to Recover Losses
- Needham Starts Immix Biopharma, Inc. (IMMX) at Buy
- Immix Biopharma shares fall 13% after executive arrested as fugitive
Entities mentioned with IMMX
- FDA | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- IPO | View Related Stories »
- ThinkEquity | View Related Stories »
- 13G | View Related Stories »
- S3 | View Related Stories »
- Show More...
